Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 Pneumonia

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
COVID-19
Interventions
DRUG

DILTIAZEM TEVA 60 mg or placebo

DILTIAZEM TEVA 60 mg 3 times a day during 7 days + standard of care Or placebo 3 times a day during 7 days + standard of care.

Trial Locations (21)

13015

Clinique des bronches, de l'allergie et du sommeil Hôpital Nord, Marseille

25030

Service de Pneumologie, CHU Besançon, Besançon

31059

Clinique des Voies Respiratoires Hôpital Larrey, Toulouse

33604

Service de pneumologie Hôpital Haut-Leveque, Bordeaux

34295

Pulmonology department CHU Montpellier, Montpellier

38043

Maladies infectieuses et Tropicales CHU Grenoble Rhône-Alpes, Grenoble

42055

Department of Pulmonology-Thoracic Oncology, University Hospital of SaintEtienne, Saint-Etienne

49100

Département de Pneumologie, CHU Angers, Angers

59208

Service des Maladies Infectieuses et du Voyageur Hôpital Gustave Dron, Tourcoing

63000

Service de Pneumologie CHU Gabriel Montpied, Clermont-Ferrand

67000

Service de pneumologie, CHRU Strasbourg, Strasbourg

69004

Departement of Pulmonology, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon

Médecine Interne, Hôpital de la Croix- Rousse, HOSPICES CIVILS DE LYON, Lyon

69310

Service de pneumologie, CHLS, Hospices Civils de Lyon, Pierre-Bénite

75018

Service Pneumologie, Hôpital BICHAT, Paris

75651

Service de Pneumologie, GHU APHP-Sorbonne Université, site Pitié Salpêtrière, Paris

76290

de Pneumologie Groupe Hospitalier du Havre Hôpital, Montivilliers

80054

respiratory department Amiens Hospital, Amiens

Service de Maladies infectieuses et tropicales, Amiens

97261

Service des Maladies Infectieuses et Tropicales, Fort-de-France

Unknown

Médecine interne, CHMS, Hospices Civils de Lyon, Pierre-Bénite

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Signia Therapeutics

UNKNOWN

lead

Hospices Civils de Lyon

OTHER

NCT05563168 - Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 Pneumonia | Biotech Hunter | Biotech Hunter